JOURNAL OF CELLULAR AND MOLECULAR MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2176817, encodeId=33c321e6817d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：生信还接受吗？投稿可以联系我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:18:49 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1242793, encodeId=746c1242e9305, content=偏重的研究方向：药理;心血管 经验分享：从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，没有让我修稿，就是在等着总编辑意见，肿么办…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2e36527084, createdName=ms3000000591411587, createdTime=Fri Sep 02 13:35:24 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164326, encodeId=326521643260b, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：三个多月了还在under review。。。要不要转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOnpl8fRB9rwYn0gah563vDD4uAanAn2jst0r1yXPMDL2g8kLMpC7A8hEIJPIEaC8KIYoKY3iaPpg/132, createdBy=347e5268719, createdName=zxywzfs, createdTime=Mon Oct 23 09:09:45 CST 2023, time=2023-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=953050, encodeId=645195305075, content=Awaiting ED assignment 大概要多久呀，投稿10天了一直是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57955078552, createdName=145aa669m96暂无昵称, createdTime=Thu Apr 01 12:56:08 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113362, encodeId=54ac211336298, content=所以这个杂志现在要带marker的WB条带吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3c38243251, createdName=ms8000000803184690, createdTime=Tue Feb 07 09:16:35 CST 2023, time=2023-02-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2164055, encodeId=9eb221640558e, content=版面费4510美金。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015d8711457, createdName=ms3000000096003158, createdTime=Sat Oct 21 09:27:55 CST 2023, time=2023-10-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2113503, encodeId=cb8e211350341, content=偏重的研究方向：细胞生物学 经验分享：想问问大家ADM under review 持续多久啊？这状态是送审了吗？下一个状态应该是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8eca5520595, createdName=ms7000000961661264, createdTime=Tue Feb 07 17:00:59 CST 2023, time=2023-02-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111825, encodeId=42f3211182535, content=有没有小伙伴知道Awaiting EIC Decision这个状态一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Sat Jan 28 10:50:36 CST 2023, time=2023-01-28, status=1, ipAttribution=山东省)]

2023-12-24 投稿中来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：生信
经验分享：生信还接受吗？投稿可以联系我

20 0

[GetPortalCommentsPageByObjectIdResponse(id=2176817, encodeId=33c321e6817d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：生信还接受吗？投稿可以联系我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:18:49 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1242793, encodeId=746c1242e9305, content=偏重的研究方向：药理;心血管 经验分享：从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，没有让我修稿，就是在等着总编辑意见，肿么办…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2e36527084, createdName=ms3000000591411587, createdTime=Fri Sep 02 13:35:24 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164326, encodeId=326521643260b, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：三个多月了还在under review。。。要不要转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOnpl8fRB9rwYn0gah563vDD4uAanAn2jst0r1yXPMDL2g8kLMpC7A8hEIJPIEaC8KIYoKY3iaPpg/132, createdBy=347e5268719, createdName=zxywzfs, createdTime=Mon Oct 23 09:09:45 CST 2023, time=2023-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=953050, encodeId=645195305075, content=Awaiting ED assignment 大概要多久呀，投稿10天了一直是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57955078552, createdName=145aa669m96暂无昵称, createdTime=Thu Apr 01 12:56:08 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113362, encodeId=54ac211336298, content=所以这个杂志现在要带marker的WB条带吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3c38243251, createdName=ms8000000803184690, createdTime=Tue Feb 07 09:16:35 CST 2023, time=2023-02-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2164055, encodeId=9eb221640558e, content=版面费4510美金。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015d8711457, createdName=ms3000000096003158, createdTime=Sat Oct 21 09:27:55 CST 2023, time=2023-10-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2113503, encodeId=cb8e211350341, content=偏重的研究方向：细胞生物学 经验分享：想问问大家ADM under review 持续多久啊？这状态是送审了吗？下一个状态应该是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8eca5520595, createdName=ms7000000961661264, createdTime=Tue Feb 07 17:00:59 CST 2023, time=2023-02-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111825, encodeId=42f3211182535, content=有没有小伙伴知道Awaiting EIC Decision这个状态一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Sat Jan 28 10:50:36 CST 2023, time=2023-01-28, status=1, ipAttribution=山东省)]

2022-09-02 ms3000000591411587

偏重的研究方向：药理;心血管
经验分享：从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，没有让我修稿，就是在等着总编辑意见，肿么办…

68 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176817, encodeId=33c321e6817d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：生信还接受吗？投稿可以联系我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:18:49 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1242793, encodeId=746c1242e9305, content=偏重的研究方向：药理;心血管 经验分享：从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，没有让我修稿，就是在等着总编辑意见，肿么办…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2e36527084, createdName=ms3000000591411587, createdTime=Fri Sep 02 13:35:24 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164326, encodeId=326521643260b, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：三个多月了还在under review。。。要不要转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOnpl8fRB9rwYn0gah563vDD4uAanAn2jst0r1yXPMDL2g8kLMpC7A8hEIJPIEaC8KIYoKY3iaPpg/132, createdBy=347e5268719, createdName=zxywzfs, createdTime=Mon Oct 23 09:09:45 CST 2023, time=2023-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=953050, encodeId=645195305075, content=Awaiting ED assignment 大概要多久呀，投稿10天了一直是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57955078552, createdName=145aa669m96暂无昵称, createdTime=Thu Apr 01 12:56:08 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113362, encodeId=54ac211336298, content=所以这个杂志现在要带marker的WB条带吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3c38243251, createdName=ms8000000803184690, createdTime=Tue Feb 07 09:16:35 CST 2023, time=2023-02-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2164055, encodeId=9eb221640558e, content=版面费4510美金。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015d8711457, createdName=ms3000000096003158, createdTime=Sat Oct 21 09:27:55 CST 2023, time=2023-10-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2113503, encodeId=cb8e211350341, content=偏重的研究方向：细胞生物学 经验分享：想问问大家ADM under review 持续多久啊？这状态是送审了吗？下一个状态应该是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8eca5520595, createdName=ms7000000961661264, createdTime=Tue Feb 07 17:00:59 CST 2023, time=2023-02-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111825, encodeId=42f3211182535, content=有没有小伙伴知道Awaiting EIC Decision这个状态一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Sat Jan 28 10:50:36 CST 2023, time=2023-01-28, status=1, ipAttribution=山东省)]

2023-10-23 zxywzfs 来自浙江省

投稿命中率:5.0
偏重的研究方向：药理学
经验分享：三个多月了还在under review。。。要不要转投

28 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176817, encodeId=33c321e6817d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：生信还接受吗？投稿可以联系我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:18:49 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1242793, encodeId=746c1242e9305, content=偏重的研究方向：药理;心血管 经验分享：从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，没有让我修稿，就是在等着总编辑意见，肿么办…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2e36527084, createdName=ms3000000591411587, createdTime=Fri Sep 02 13:35:24 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164326, encodeId=326521643260b, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：三个多月了还在under review。。。要不要转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOnpl8fRB9rwYn0gah563vDD4uAanAn2jst0r1yXPMDL2g8kLMpC7A8hEIJPIEaC8KIYoKY3iaPpg/132, createdBy=347e5268719, createdName=zxywzfs, createdTime=Mon Oct 23 09:09:45 CST 2023, time=2023-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=953050, encodeId=645195305075, content=Awaiting ED assignment 大概要多久呀，投稿10天了一直是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57955078552, createdName=145aa669m96暂无昵称, createdTime=Thu Apr 01 12:56:08 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113362, encodeId=54ac211336298, content=所以这个杂志现在要带marker的WB条带吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3c38243251, createdName=ms8000000803184690, createdTime=Tue Feb 07 09:16:35 CST 2023, time=2023-02-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2164055, encodeId=9eb221640558e, content=版面费4510美金。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015d8711457, createdName=ms3000000096003158, createdTime=Sat Oct 21 09:27:55 CST 2023, time=2023-10-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2113503, encodeId=cb8e211350341, content=偏重的研究方向：细胞生物学 经验分享：想问问大家ADM under review 持续多久啊？这状态是送审了吗？下一个状态应该是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8eca5520595, createdName=ms7000000961661264, createdTime=Tue Feb 07 17:00:59 CST 2023, time=2023-02-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111825, encodeId=42f3211182535, content=有没有小伙伴知道Awaiting EIC Decision这个状态一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Sat Jan 28 10:50:36 CST 2023, time=2023-01-28, status=1, ipAttribution=山东省)]

2021-04-01 145aa669m96暂无昵称

Awaiting ED assignment 大概要多久呀，投稿10天了一直是这个状态

1 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176817, encodeId=33c321e6817d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：生信还接受吗？投稿可以联系我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:18:49 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1242793, encodeId=746c1242e9305, content=偏重的研究方向：药理;心血管 经验分享：从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，没有让我修稿，就是在等着总编辑意见，肿么办…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2e36527084, createdName=ms3000000591411587, createdTime=Fri Sep 02 13:35:24 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164326, encodeId=326521643260b, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：三个多月了还在under review。。。要不要转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOnpl8fRB9rwYn0gah563vDD4uAanAn2jst0r1yXPMDL2g8kLMpC7A8hEIJPIEaC8KIYoKY3iaPpg/132, createdBy=347e5268719, createdName=zxywzfs, createdTime=Mon Oct 23 09:09:45 CST 2023, time=2023-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=953050, encodeId=645195305075, content=Awaiting ED assignment 大概要多久呀，投稿10天了一直是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57955078552, createdName=145aa669m96暂无昵称, createdTime=Thu Apr 01 12:56:08 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113362, encodeId=54ac211336298, content=所以这个杂志现在要带marker的WB条带吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3c38243251, createdName=ms8000000803184690, createdTime=Tue Feb 07 09:16:35 CST 2023, time=2023-02-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2164055, encodeId=9eb221640558e, content=版面费4510美金。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015d8711457, createdName=ms3000000096003158, createdTime=Sat Oct 21 09:27:55 CST 2023, time=2023-10-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2113503, encodeId=cb8e211350341, content=偏重的研究方向：细胞生物学 经验分享：想问问大家ADM under review 持续多久啊？这状态是送审了吗？下一个状态应该是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8eca5520595, createdName=ms7000000961661264, createdTime=Tue Feb 07 17:00:59 CST 2023, time=2023-02-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111825, encodeId=42f3211182535, content=有没有小伙伴知道Awaiting EIC Decision这个状态一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Sat Jan 28 10:50:36 CST 2023, time=2023-01-28, status=1, ipAttribution=山东省)]

2023-02-07 ms8000000803184690 来自福建省

所以这个杂志现在要带marker的WB条带吗

50 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176817, encodeId=33c321e6817d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：生信还接受吗？投稿可以联系我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:18:49 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1242793, encodeId=746c1242e9305, content=偏重的研究方向：药理;心血管 经验分享：从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，没有让我修稿，就是在等着总编辑意见，肿么办…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2e36527084, createdName=ms3000000591411587, createdTime=Fri Sep 02 13:35:24 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164326, encodeId=326521643260b, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：三个多月了还在under review。。。要不要转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOnpl8fRB9rwYn0gah563vDD4uAanAn2jst0r1yXPMDL2g8kLMpC7A8hEIJPIEaC8KIYoKY3iaPpg/132, createdBy=347e5268719, createdName=zxywzfs, createdTime=Mon Oct 23 09:09:45 CST 2023, time=2023-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=953050, encodeId=645195305075, content=Awaiting ED assignment 大概要多久呀，投稿10天了一直是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57955078552, createdName=145aa669m96暂无昵称, createdTime=Thu Apr 01 12:56:08 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113362, encodeId=54ac211336298, content=所以这个杂志现在要带marker的WB条带吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3c38243251, createdName=ms8000000803184690, createdTime=Tue Feb 07 09:16:35 CST 2023, time=2023-02-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2164055, encodeId=9eb221640558e, content=版面费4510美金。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015d8711457, createdName=ms3000000096003158, createdTime=Sat Oct 21 09:27:55 CST 2023, time=2023-10-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2113503, encodeId=cb8e211350341, content=偏重的研究方向：细胞生物学 经验分享：想问问大家ADM under review 持续多久啊？这状态是送审了吗？下一个状态应该是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8eca5520595, createdName=ms7000000961661264, createdTime=Tue Feb 07 17:00:59 CST 2023, time=2023-02-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111825, encodeId=42f3211182535, content=有没有小伙伴知道Awaiting EIC Decision这个状态一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Sat Jan 28 10:50:36 CST 2023, time=2023-01-28, status=1, ipAttribution=山东省)]

2023-10-21 ms3000000096003158 来自安徽省

版面费4510美金。。。

30 0

[GetPortalCommentsPageByObjectIdResponse(id=2176817, encodeId=33c321e6817d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：生信还接受吗？投稿可以联系我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:18:49 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1242793, encodeId=746c1242e9305, content=偏重的研究方向：药理;心血管 经验分享：从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，没有让我修稿，就是在等着总编辑意见，肿么办…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2e36527084, createdName=ms3000000591411587, createdTime=Fri Sep 02 13:35:24 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164326, encodeId=326521643260b, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：三个多月了还在under review。。。要不要转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOnpl8fRB9rwYn0gah563vDD4uAanAn2jst0r1yXPMDL2g8kLMpC7A8hEIJPIEaC8KIYoKY3iaPpg/132, createdBy=347e5268719, createdName=zxywzfs, createdTime=Mon Oct 23 09:09:45 CST 2023, time=2023-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=953050, encodeId=645195305075, content=Awaiting ED assignment 大概要多久呀，投稿10天了一直是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57955078552, createdName=145aa669m96暂无昵称, createdTime=Thu Apr 01 12:56:08 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113362, encodeId=54ac211336298, content=所以这个杂志现在要带marker的WB条带吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3c38243251, createdName=ms8000000803184690, createdTime=Tue Feb 07 09:16:35 CST 2023, time=2023-02-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2164055, encodeId=9eb221640558e, content=版面费4510美金。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015d8711457, createdName=ms3000000096003158, createdTime=Sat Oct 21 09:27:55 CST 2023, time=2023-10-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2113503, encodeId=cb8e211350341, content=偏重的研究方向：细胞生物学 经验分享：想问问大家ADM under review 持续多久啊？这状态是送审了吗？下一个状态应该是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8eca5520595, createdName=ms7000000961661264, createdTime=Tue Feb 07 17:00:59 CST 2023, time=2023-02-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111825, encodeId=42f3211182535, content=有没有小伙伴知道Awaiting EIC Decision这个状态一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Sat Jan 28 10:50:36 CST 2023, time=2023-01-28, status=1, ipAttribution=山东省)]

2023-09-12 ms1000000858912769 来自华盛顿

生信加实验会收吗

23 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176817, encodeId=33c321e6817d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：生信还接受吗？投稿可以联系我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:18:49 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1242793, encodeId=746c1242e9305, content=偏重的研究方向：药理;心血管 经验分享：从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，没有让我修稿，就是在等着总编辑意见，肿么办…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2e36527084, createdName=ms3000000591411587, createdTime=Fri Sep 02 13:35:24 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164326, encodeId=326521643260b, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：三个多月了还在under review。。。要不要转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOnpl8fRB9rwYn0gah563vDD4uAanAn2jst0r1yXPMDL2g8kLMpC7A8hEIJPIEaC8KIYoKY3iaPpg/132, createdBy=347e5268719, createdName=zxywzfs, createdTime=Mon Oct 23 09:09:45 CST 2023, time=2023-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=953050, encodeId=645195305075, content=Awaiting ED assignment 大概要多久呀，投稿10天了一直是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57955078552, createdName=145aa669m96暂无昵称, createdTime=Thu Apr 01 12:56:08 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113362, encodeId=54ac211336298, content=所以这个杂志现在要带marker的WB条带吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3c38243251, createdName=ms8000000803184690, createdTime=Tue Feb 07 09:16:35 CST 2023, time=2023-02-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2164055, encodeId=9eb221640558e, content=版面费4510美金。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015d8711457, createdName=ms3000000096003158, createdTime=Sat Oct 21 09:27:55 CST 2023, time=2023-10-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2113503, encodeId=cb8e211350341, content=偏重的研究方向：细胞生物学 经验分享：想问问大家ADM under review 持续多久啊？这状态是送审了吗？下一个状态应该是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8eca5520595, createdName=ms7000000961661264, createdTime=Tue Feb 07 17:00:59 CST 2023, time=2023-02-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111825, encodeId=42f3211182535, content=有没有小伙伴知道Awaiting EIC Decision这个状态一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Sat Jan 28 10:50:36 CST 2023, time=2023-01-28, status=1, ipAttribution=山东省)]

2023-02-07 ms7000000961661264 来自甘肃省

偏重的研究方向：细胞生物学
经验分享：想问问大家ADM under review 持续多久啊？这状态是送审了吗？下一个状态应该是什么？

45 0

[GetPortalCommentsPageByObjectIdResponse(id=2176817, encodeId=33c321e6817d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：生信还接受吗？投稿可以联系我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:18:49 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1242793, encodeId=746c1242e9305, content=偏重的研究方向：药理;心血管 经验分享：从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，没有让我修稿，就是在等着总编辑意见，肿么办…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2e36527084, createdName=ms3000000591411587, createdTime=Fri Sep 02 13:35:24 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164326, encodeId=326521643260b, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：三个多月了还在under review。。。要不要转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOnpl8fRB9rwYn0gah563vDD4uAanAn2jst0r1yXPMDL2g8kLMpC7A8hEIJPIEaC8KIYoKY3iaPpg/132, createdBy=347e5268719, createdName=zxywzfs, createdTime=Mon Oct 23 09:09:45 CST 2023, time=2023-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=953050, encodeId=645195305075, content=Awaiting ED assignment 大概要多久呀，投稿10天了一直是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57955078552, createdName=145aa669m96暂无昵称, createdTime=Thu Apr 01 12:56:08 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113362, encodeId=54ac211336298, content=所以这个杂志现在要带marker的WB条带吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3c38243251, createdName=ms8000000803184690, createdTime=Tue Feb 07 09:16:35 CST 2023, time=2023-02-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2164055, encodeId=9eb221640558e, content=版面费4510美金。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015d8711457, createdName=ms3000000096003158, createdTime=Sat Oct 21 09:27:55 CST 2023, time=2023-10-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2113503, encodeId=cb8e211350341, content=偏重的研究方向：细胞生物学 经验分享：想问问大家ADM under review 持续多久啊？这状态是送审了吗？下一个状态应该是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8eca5520595, createdName=ms7000000961661264, createdTime=Tue Feb 07 17:00:59 CST 2023, time=2023-02-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111825, encodeId=42f3211182535, content=有没有小伙伴知道Awaiting EIC Decision这个状态一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Sat Jan 28 10:50:36 CST 2023, time=2023-01-28, status=1, ipAttribution=山东省)]

2021-12-20 916603706

从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，

0 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2176817, encodeId=33c321e6817d2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生信 经验分享：生信还接受吗？投稿可以联系我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqNZjGy4w5YZ0nnUWYokllg4nOIU4USYQniaUH0BCPrjHqwia1BLT0JTsKs9TO48UI8buibYsgVlVZ1w/132, createdBy=47272002716, createdName=投稿中, createdTime=Sun Dec 24 11:18:49 CST 2023, time=2023-12-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1242793, encodeId=746c1242e9305, content=偏重的研究方向：药理;心血管 经验分享：从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，没有让我修稿，就是在等着总编辑意见，肿么办…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2e36527084, createdName=ms3000000591411587, createdTime=Fri Sep 02 13:35:24 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164326, encodeId=326521643260b, content=投稿命中率:5.0 偏重的研究方向：药理学 经验分享：三个多月了还在under review。。。要不要转投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKOnpl8fRB9rwYn0gah563vDD4uAanAn2jst0r1yXPMDL2g8kLMpC7A8hEIJPIEaC8KIYoKY3iaPpg/132, createdBy=347e5268719, createdName=zxywzfs, createdTime=Mon Oct 23 09:09:45 CST 2023, time=2023-10-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=953050, encodeId=645195305075, content=Awaiting ED assignment 大概要多久呀，投稿10天了一直是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57955078552, createdName=145aa669m96暂无昵称, createdTime=Thu Apr 01 12:56:08 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113362, encodeId=54ac211336298, content=所以这个杂志现在要带marker的WB条带吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3c38243251, createdName=ms8000000803184690, createdTime=Tue Feb 07 09:16:35 CST 2023, time=2023-02-07, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2164055, encodeId=9eb221640558e, content=版面费4510美金。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015d8711457, createdName=ms3000000096003158, createdTime=Sat Oct 21 09:27:55 CST 2023, time=2023-10-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2113503, encodeId=cb8e211350341, content=偏重的研究方向：细胞生物学 经验分享：想问问大家ADM under review 持续多久啊？这状态是送审了吗？下一个状态应该是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8eca5520595, createdName=ms7000000961661264, createdTime=Tue Feb 07 17:00:59 CST 2023, time=2023-02-07, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1081948, encodeId=7419108194804, content=从under review，到Awaiting ED Recommendation，现在到Awaiting EIC Decision，好紧张啊，天哪，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 20 00:35:53 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111825, encodeId=42f3211182535, content=有没有小伙伴知道Awaiting EIC Decision这个状态一般要多久呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16a05431152, createdName=cyrain, createdTime=Sat Jan 28 10:50:36 CST 2023, time=2023-01-28, status=1, ipAttribution=山东省)]

2023-01-28 cyrain 来自山东省

有没有小伙伴知道Awaiting EIC Decision这个状态一般要多久呀？

99 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务